Efficacy of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists on proteinuria and weight in a diabetes cohort
Compared with patients who received other glucose-lowering drugs, patients receiving SGLT2i or GLP-1RAs presented significant weight loss, a decreasing trend in UACR and comparable glucose-lowering effects in real-world settings.
Authors
- Difei Lu (ORCID: https://orcid.org/0000-0003-3953-8900)
- Ang Li (ORCID: https://orcid.org/0000-0002-1948-344X)
- Junqing Zhang (ORCID: https://orcid.org/0000-0002-8574-1945)
- Rui Zheng
Institutions
- Peking University (CN)
- Peking University First Hospital (CN)
Publication Details
- Journal
- World Journal of Diabetes
- Published
- 2024-12-30
- DOI
- https://doi.org/10.4239/wjd.v16.i2.98552
- Citations
- 1
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.36